748 related articles for article (PubMed ID: 23262793)
21. Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging: differentiation of benign and malignant breast lesions.
Daldrup-Link HE; Kaiser A; Helbich T; Werner M; Bjørnerud A; Link TM; Rummeny EJ
Acad Radiol; 2003 Nov; 10(11):1237-46. PubMed ID: 14626298
[TBL] [Abstract][Full Text] [Related]
22. Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T.
Essig M; Lodemann KP; Le-Huu M; Brüning R; Kirchin M; Reith W
Invest Radiol; 2006 Mar; 41(3):256-63. PubMed ID: 16481908
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of spontaneous canine breast tumors using dynamic magnetic resonance imaging with 24-Gadolinium-DTPA-cascade-polymer, a new blood-pool agent. Preliminary experience.
Adam G; Mühler A; Spüntrup E; Neuerburg JM; Kilbinger M; Bauer H; Fücezi L; Küpper W; Günther RW
Invest Radiol; 1996 May; 31(5):267-74. PubMed ID: 8724124
[TBL] [Abstract][Full Text] [Related]
24. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
Chen W; Giger ML; Bick U; Newstead GM
Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
[TBL] [Abstract][Full Text] [Related]
25. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
[TBL] [Abstract][Full Text] [Related]
26. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.
Johansson L; Kirchin MA; Ahlström H
Acta Radiol; 2012 Dec; 53(10):1112-7. PubMed ID: 23081961
[TBL] [Abstract][Full Text] [Related]
27. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography.
Gribbestad IS; Nilsen G; Fjøsne HE; Kvinnsland S; Haugen OA; Rinck PA
J Magn Reson Imaging; 1994; 4(3):477-80. PubMed ID: 8061451
[TBL] [Abstract][Full Text] [Related]
28. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
[TBL] [Abstract][Full Text] [Related]
29. Comparison of models and contrast agents for improved signal and signal linearity in dynamic contrast-enhanced pulmonary magnetic resonance imaging.
Bell LC; Wang K; Munoz Del Rio A; Grist TM; Fain SB; Nagle SK
Invest Radiol; 2015 Mar; 50(3):174-8. PubMed ID: 25501016
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Dynamic Contrast-Enhancement Parameters between Gadobutrol and Gadoterate Meglumine in Posttreatment Glioma: A Prospective Intraindividual Study.
Park JE; Kim JY; Kim HS; Shim WH
AJNR Am J Neuroradiol; 2020 Nov; 41(11):2041-2048. PubMed ID: 33060100
[TBL] [Abstract][Full Text] [Related]
31. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
32. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
[TBL] [Abstract][Full Text] [Related]
33. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
[TBL] [Abstract][Full Text] [Related]
34. Improving suspicious breast lesion characterization using semi-automatic lesion fractional volume washout kinetic analysis.
Huang J; Hahn T; Hoisington L; Schafer S; Zong X; Berger K
Med Phys; 2011 Nov; 38(11):5998-6009. PubMed ID: 22047364
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
[TBL] [Abstract][Full Text] [Related]
36. [Controlled study of gadobenate dimeglumine versus gadopentetate in breast tumor MR dynamic enhancement scanning].
Yang X; Liu G; Yu X; Zhang Q; Zhang W; Guo Y
Zhonghua Yi Xue Za Zhi; 2015 Jul; 95(25):2003-5. PubMed ID: 26710810
[TBL] [Abstract][Full Text] [Related]
37. Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine Model.
Kang Y; Choi JY; Yoo HJ; Hong SH; Kang HS
Radiology; 2017 Mar; 282(3):734-742. PubMed ID: 27649101
[TBL] [Abstract][Full Text] [Related]
38. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
Hauth EA; Jaeger HJ; Maderwald S; Muehler A; Kimmig R; Forsting M
Eur J Radiol; 2008 May; 66(2):300-8. PubMed ID: 17658235
[TBL] [Abstract][Full Text] [Related]
39. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
